Agios Pharmaceuticals AGIO
$27.60 −$1.16 (-4.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.60 0.00%
Open$28.01
Prev close$28.76
Day range$27.43 – $29.14
Volume776.2K
Market cap$1.65B
P/E (TTM)–
Dividend yield–
AGIO Stock News
Headlines matching Agios Pharmaceuticals or the AGIO ticker, most recent first.
- BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $50 Positive
- TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
- Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
- A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $41 to $54
- BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $46 Positive
- Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39
- A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $39 to $55
- BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $46
- H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Cuts Target Price to $52 Negative
- H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $54
- H.C. Wainwright Remains a Buy on Agios Pharma (AGIO)
- Goldman Sachs Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Raises Target Price to $32 Positive
- H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $50
- A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $36 to $54
- Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $36
No comments yet — be the first to weigh in on AGIO.
Sign in to join the discussion.